Cerus (CERS) Net Margin Growth (1y) (2011 - 2026)
Cerus (CERS) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -430.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 656.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 1,478.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,478.00 |
| Dec 31, 2025 | 1,602.00 |
| Sep 30, 2025 | 626.00 |
| Jun 30, 2025 | -3,230.00 |
| Mar 31, 2025 | 17,479.00 |
| Dec 31, 2024 | -2,423.00 |
| Sep 30, 2024 | 1,194.00 |
| Jun 30, 2024 | 153,930.00 |
| Mar 31, 2024 | -8,115.00 |
| Dec 31, 2023 | 3,246.00 |
| Sep 30, 2023 | 224,189.00 |
| Jun 30, 2023 | -152,503.00 |
| Mar 31, 2023 | -2,851.00 |
| Dec 31, 2022 | -5,248.00 |
| Sep 30, 2022 | 180,417.00 |
| Jun 30, 2022 | 247,847.00 |
| Mar 31, 2022 | 390,263.00 |
| Dec 31, 2021 | 5,532.00 |
| Sep 30, 2021 | -381,117.00 |
| Jun 30, 2021 | -225,550.00 |